SULFAMETHOXAZOLE AND TRIMETHOPRIM vs TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

Compare SULFAMETHOXAZOLE AND TRIMETHOPRIM (Sulfamethoxazole and Trimethoprim) and TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE (Trimethoprim sulfate and Polymyxin B sulfate) — clinical data, side effects, and patient experiences.

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Sulfamethoxazole and Trimethoprim · Sulfonamide Antibiotic

How it works

Other agent

Approved for

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets

USP and other antibacterial drugs

sulfamethoxazole and trimethoprim tablets

USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available

OralTablet

TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

Trimethoprim sulfate and Polymyxin B sulfate · Sulfonamide Antibiotic

How it works

Other agent

Approved for

INDICATIONS AND USAGE Trimethoprim Sulfate and Polymyxin B Sulfate Ophthalmic Solution is indicated in the treatment of surface ocular bacterial infections

including acute bacterial conjunctivitis

and blepharoconjunctivitis

caused by susceptible strains of the following microorganisms: Staphylococcus aureus

OphthalmicTablet

Quick Comparison

SULFAMETHOXAZOLE AND TRIMETHOPRIMTRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

Drug Class

Sulfonamide Antibiotic

Route

Oral

Ophthalmic

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Fever

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Nausea

1-10%

Rash

1-10%

Shortness of Breath

1-10%

Vomiting

1-10%

Drug Not Working

1-10%

TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

Fever

1-10%

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Rash

1-10%

Shortness of Breath

1-10%

Vomiting

1-10%

Drug Not Working

1-10%

FDA Warnings

SULFAMETHOXAZOLE AND TRIMETHOPRIM

WARNINGS Embryofetal Toxicity Some epidemiologic studies suggest that exposure to sulfamethoxazole and trimethoprim during pregnancy may be associated with an increased risk of congenital malformations, particularly neural tube defects, cardiovascular malformations, urinary tract defects, oral clefts, and club foot
Hypersensitivity and Other Fatal Reactions Fatalities associated with the administration of sulfonamides, although rare, have occurred due to severe reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia and other blood dyscrasias
In rare instances, a skin rash may be followed by a more severe reaction, such as Stevens-Johnson syndrome, toxic epidermal necrolysis, hepatic necrosis, and serious blood disorders (see PRECAUTIONS )
Clinical signs, such as rash, sore throat, fever, arthralgia, pallor, purpura or jaundice may be early indications of serious reactions

TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

WARNINGS NOT FOR INJECTION INTO THE EYE

Clinical Trial Data

No head-to-head clinical studies found for SULFAMETHOXAZOLE AND TRIMETHOPRIM vs TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE.

SULFAMETHOXAZOLE AND TRIMETHOPRIM vs TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE: What You Should Know

Key Differences

Both SULFAMETHOXAZOLE AND TRIMETHOPRIM and TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE belong to the Sulfonamide Antibiotic class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. SULFAMETHOXAZOLE AND TRIMETHOPRIM is administered via Oral, whereas TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE uses Ophthalmic. Route of administration can affect onset of action and patient adherence.

Safety Considerations

SULFAMETHOXAZOLE AND TRIMETHOPRIM carries 4 FDA warnings. TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE carries 1 FDA warning. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

POLYMYXIN B SULFATE AND TRIMETHOPRIM vs SULFAMETHOXAZOLE AND TRIMETHOPRIM→POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE vs SULFAMETHOXAZOLE AND TRIMETHOPRIM→SULFAMETHOXAZOLE AND TRIMETHOPRIM vs TRIMETHOPRIM→POLYMYXIN B SULFATE AND TRIMETHOPRIM vs TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE→POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE vs TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE→TRIMETHOPRIM vs TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE→

Loading comparison data...

SULFAMETHOXAZOLE AND TRIMETHOPRIM vs TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Sulfamethoxazole and Trimethoprim · Sulfonamide Antibiotic

How it works

Other agent

Approved for

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets

USP and other antibacterial drugs

sulfamethoxazole and trimethoprim tablets

USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available

OralTablet

TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

Trimethoprim sulfate and Polymyxin B sulfate · Sulfonamide Antibiotic

How it works

Other agent

Approved for

INDICATIONS AND USAGE Trimethoprim Sulfate and Polymyxin B Sulfate Ophthalmic Solution is indicated in the treatment of surface ocular bacterial infections

including acute bacterial conjunctivitis

and blepharoconjunctivitis

caused by susceptible strains of the following microorganisms: Staphylococcus aureus

OphthalmicTablet

Quick Comparison

SULFAMETHOXAZOLE AND TRIMETHOPRIMTRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

Drug Class

Sulfonamide Antibiotic

Route

Oral

Ophthalmic

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Fever

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Nausea

1-10%

Rash

1-10%

Shortness of Breath

1-10%

Vomiting

1-10%

Drug Not Working

1-10%

TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

Fever

1-10%

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Rash

1-10%

Shortness of Breath

1-10%

Vomiting

1-10%

Drug Not Working

1-10%

FDA Warnings

SULFAMETHOXAZOLE AND TRIMETHOPRIM

WARNINGS Embryofetal Toxicity Some epidemiologic studies suggest that exposure to sulfamethoxazole and trimethoprim during pregnancy may be associated with an increased risk of congenital malformations, particularly neural tube defects, cardiovascular malformations, urinary tract defects, oral clefts, and club foot
Hypersensitivity and Other Fatal Reactions Fatalities associated with the administration of sulfonamides, although rare, have occurred due to severe reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia and other blood dyscrasias
In rare instances, a skin rash may be followed by a more severe reaction, such as Stevens-Johnson syndrome, toxic epidermal necrolysis, hepatic necrosis, and serious blood disorders (see PRECAUTIONS )
Clinical signs, such as rash, sore throat, fever, arthralgia, pallor, purpura or jaundice may be early indications of serious reactions

TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

WARNINGS NOT FOR INJECTION INTO THE EYE

Clinical Trial Data

No head-to-head clinical studies found for SULFAMETHOXAZOLE AND TRIMETHOPRIM vs TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE.

SULFAMETHOXAZOLE AND TRIMETHOPRIM vs TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.